Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

  • This share is currently suspended. It was suspended at a price of 440.00
  • There is currently no data for MRL

Capital Reduction Effective

18 Jul 2023 12:15

RNS Number : 4005G
Marlowe PLC
18 July 2023
 

18 July 2023

 

Marlowe plc

 

Capital Reduction Effective

 

At a general meeting of Marlowe plc (the "Company") held on 19 June 2023 (the "General Meeting"), a resolution was passed by shareholders to cancel the balance standing to the credit of the share premium account of the Company, in doing so increasing the distributable reserves of the Company by £384,921,004.09 (the "Capital Reduction").

 

To be effective, the Capital Reduction required Court approval and the Company is pleased to announce that Court approval has now been obtained and the Capital Reduction is now effective. This follows the Court order approving the reduction of capital which was registered with Companies House on 17 July 2023.

 

Whilst the Board and management remain focussed on the continued execution of the Company's stated growth strategy, the Capital Reduction now removes a potential restriction on the Company's ability to either make dividend payments and other distributions or to purchase its own shares in the future. The Capital Reduction will not change the number of Ordinary Shares in issue or the paid up share capital of the Company or change any rights attaching to the Ordinary Shares.

 

 

For further information:

 

Marlowe plc

Alex Dacre, Chief Executive

www.marloweplc.com

Adam Councell, Chief Financial Officer

Tel: +44 (0) 203 813 8498

Benjamin Tucker, Investor Relations Manager

IR@marloweplc.com

Cenkos Securities plc (Nominated Adviser and Joint Broker)

Ben Jeynes

Tel: +44 (0)20 7397 8900

George Lawson

Berenberg (Joint Broker)

Ben Wright

Tel: +44 (0)20 3207 7800

Mark Whitmore

Stifel (Joint Broker)

Matthew Blawat

Tel: +44 (0)20 7710 7688

Francis North

FTI Consulting

Nick Hasell

Tel: +44 (0)20 3727 1340

Alex Le May

 

 

About Marlowe plc

Marlowe is a leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUWGMUPWGGR
Date   Source Headline
19th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20248:58 amRNSHolding(s) in Company
9th Dec 20248:14 amRNSHolding(s) in Company
9th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSInterim results for the six months to 30 Sept 2024
29th Nov 20244:30 pmRNSTotal Voting Rights
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:02 amRNSTransaction in Own Shares
14th Nov 20249:29 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSChange of Adviser
5th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20244:58 pmRNSTotal Voting Rights
1st Nov 20249:23 amRNSHolding(s) in Company
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20241:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 202411:40 amRNSBlock listing Interim Review
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 20244:32 pmRNSResult of Annual General Meeting
30th Sep 20244:18 pmRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSAGM Statement
23rd Sep 202410:23 amRNSFurther re Demerger of Optima Health
20th Sep 20244:30 pmRNSTotal Voting Rights
12th Sep 20247:00 amRNSDemerger of Occupational Health division
23rd Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.